APX Acquisition Corp. I Announces Nasdaq Delisting Notification for Warrants and Units PR Newswire NASHVILLE, Tenn., Nov. 1, 2024 NASHVILLE, Tenn., Nov. 1, 2024 /PRNewswire/ -- As previously...
APX Acquisition Corp. I Reports 10-K Delinquency Notice PR Newswire NASHVILLE, Tenn., June 5, 2024 NASHVILLE, Tenn., June 5, 2024 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI...
APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd enter into Business Combination Agreement to create a global AI-driven genomics platform PR Newswire NASHVILLE, Tenn., March...
APX Acquisition Corp. I receives Nasdaq notice on late filing of its Form 10-Q PR Newswire NASHVILLE, Tenn., Dec. 28, 2023 NASHVILLE, Tenn., Dec. 28, 2023 /PRNewswire/ -- APX Acquisition Corp. I...
APX Acquisition Corp. I & Bioceres Group Announce Letter of Intent for a Business Combination with a Precision Medicine Diagnostic and Wellness Services Company PR Newswire NASHVILLE, Tenn...
APx Acquisition Corp. I (“APx” or the “Company”), a special purpose acquisition company, announced today that at the extraordinary general shareholders meeting held on February 27, 2023, the...
APx Acquisition Corp. I (NASDAQ: APXI) (“APx” or the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 11.9 | 11.9 | 11.9 | 0 | 0 | CS |
4 | -0.35 | -2.85714285714 | 12.25 | 12.25 | 11.68 | 71 | 11.89956009 | CS |
12 | 0.17 | 1.44927536232 | 11.73 | 13.17 | 11.5 | 2826 | 11.82917665 | CS |
26 | 0.31 | 2.67471958585 | 11.59 | 13.17 | 11.45 | 5743 | 11.70267691 | CS |
52 | 0.7 | 6.25 | 11.2 | 13.17 | 11.2 | 10525 | 11.45649421 | CS |
156 | 1.9 | 19 | 10 | 13.17 | 9.8 | 22213 | 10.45071197 | CS |
260 | 1.9 | 19 | 10 | 13.17 | 9.8 | 22213 | 10.45071197 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions